FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
FAM177A1 | Family with sequence similarity 177, member A1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM213A | Family with sequence similarity 213, member A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM3C | Family with sequence similarity 3, member C | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
FBN1 | Fibrillin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FGA | Fibrinogen alpha chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FHL1 | Four and a half LIM domains 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
FKBP10 | FK506 binding protein 10, 65 kDa | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
FLOT1 | Flotillin 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FRYL | FRY-like | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GBA | Glucosidase, beta, acid | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GBAS | Glioblastoma amplified sequence | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
GLS | Glutaminase | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GNS | Glucosamine (N-acetyl)-6-sulfatase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GOLM1 | Golgi membrane protein 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GTPBP10 | GTP-binding protein 10 (putative) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HMGN5 | High mobility group nucleosome binding domain 5 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
HSD17B10 | Hydroxysteroid (17-beta) dehydrogenase 10 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HSD17B11 | Hydroxysteroid (17-beta) dehydrogenase 11 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPA5 | Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IGFLR1 | IGF-like family receptor 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IGJ | Immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
IRF2BP2 | Interferon regulatory factor 2 binding protein 2 | Predicted intracellular proteins
| | | | | Expressed in all |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KAT5 | K(lysine) acetyltransferase 5 | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KDELC2 | KDEL (Lys-Asp-Glu-Leu) containing 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
KDSR | 3-ketodihydrosphingosine reductase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KLC4 | Kinesin light chain 4 | Predicted intracellular proteins
| | | | | Expressed in all |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMA4 | Laminin, alpha 4 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
LAMB1 | Laminin, beta 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
LAMC1 | Laminin, gamma 1 (formerly LAMB2) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT2 | Linker for activation of T cells family, member 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |